Figure 1.
Flow diagram of the study participants.
The total number of women who received the first and second treatment doses and were followed until delivery.
Table 1.
The baseline characteristics of the pregnant women enrolled into the clinical trial
Table 2.
Maternal and fetal outcomes according to treatment group
Table 3.
Details related to the adverse pregnancy outcomes
Figure 2.
Recrudescence rates according to the number of treatment doses.
The recrudescence rates in the three treatment groups after receiving each treatment.
Figure 3.
The overall rate of recrudescence according to treatment group.
The overall recrudescence rates comparing the three treatment groups after adjusting for baseline parasite density and gravidity.